Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2012
03/14/2012CN102372668A Preparation method for 2,6-dimethyl pyridine
03/14/2012CN102372667A Preparation method for 2,4,6-trimethyl pyridine
03/14/2012CN102372666A Method for synthesizing alfa-methylpyridine through continuous catalytic distillation
03/14/2012CN102372665A Aryl compound and application
03/14/2012CN102372664A Fluorene compound containing pyridyl and application thereof
03/14/2012CN102372663A Pyridyl indenofluorene compound and application thereof
03/14/2012CN102372532A Palladium-catalyzed ortho-orientation nitrification method of aza calixarene compounds
03/14/2012CN101624369B Aromatic heterocyclic substituted salicylaldehyde derivatives and preparation method thereof
03/14/2012CN101318953B Insecticidal activity compound
03/13/2012US8134015 Compound inhibiting in vivo phosphorous transport and medicine containing the same
03/13/2012US8134009 Process for the oxidation of secondary amines into the corresponding nitroxides
03/13/2012US8133909 Heteroaromatic monoamides as orexinin receptor antagonists
03/13/2012US8133907 Type II diabetes, obesity, hyperglycemia and a lipid disorder selected from dyslipidemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL and high LDL; additionally comprising metformin
03/13/2012US8133894 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
03/13/2012CA2514037C Crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide
03/13/2012CA2435126C Process
03/08/2012WO2012031199A1 Guanidine compounds and compositions for the inhibition of nampt
03/08/2012WO2012031196A1 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
03/08/2012WO2012031018A1 Methods and formulations of treating thrombosis with betrixaban and a p-glycoprotein inhibitor
03/08/2012WO2012031017A1 CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
03/08/2012WO2012029963A1 Process for production of aromatic amine compound
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029672A1 Noxious organism control agent
03/08/2012WO2012029432A1 Carboxylate metal complex and catalyst for olefin polymerization
03/08/2012WO2012029411A1 Method for producing biaryl compound
03/08/2012WO2012028676A1 New compounds, pharmaceutical compositions and uses thereof
03/08/2012WO2012028629A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors
03/08/2012WO2012028563A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012WO2012007877A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012007869A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012004678A3 Serine protease inhibitors
03/08/2012WO2012003912A8 Bipyridyl derivatives useful for the treatment of kinase - induced diseases
03/08/2012WO2012000608A3 Novel beta-aminoaldehyde derivatives, process for their preparation and their chemical use as reactive intermediates
03/08/2012US20120059039 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
03/08/2012US20120058985 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012CA2810049A1 Guanidine compounds and compositions for the inhibition of nampt
03/08/2012CA2810004A1 Crystalline forms of a factor xa inhibitor
03/08/2012CA2809391A1 4-{[(pyridin-3-yl-methyl)aminocarbonyl]amino}benzene-sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
03/08/2012CA2809222A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012CA2809112A1 Cyclic amide derivative
03/08/2012CA2808144A1 Pest control agent
03/07/2012EP2426191A1 Process for the homogenous hydrogenation of (poly)unsaturated hydrocarbons
03/07/2012EP2426125A1 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
03/07/2012EP2426122A1 Methylene urea derivative as RAF kinasse inhibitors
03/07/2012EP2426119A1 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3- (4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426109A1 Novel kinase inhibitors
03/07/2012EP2426108A1 Processes and intermediates for preparing fused heterocyclic kinase inhibitors
03/07/2012EP2424841A1 Pyridinone antagonists of alpha-4 integrins
03/07/2012EP2424840A1 Cxcr3 receptor antagonists
03/07/2012EP1842847B1 Process for production of 5-chloro-2,4-dihydroxypyridine
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/07/2012CN102369188A Substituted nicotinamides as KCNQ2/3 modulators
03/07/2012CN102369187A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
03/07/2012CN101381339B Prodrugs of gaba analogs, compositions and uses thereof
03/07/2012CN101330129B Oxocarbon, pseudo oxocarbon and radialene compounds and their use
03/07/2012CN101316820B Process for preparation of chiral amlodipine gentisate
03/06/2012US8129539 Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
03/06/2012US8129538 Renin inhibitors
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129534 Chemical compounds
03/06/2012US8129529 UV excitable fluorescent energy transfer dyes
03/06/2012US8129388 Therapeutic agents useful for treating pain
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/06/2012US8129137 Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe
03/01/2012WO2012027274A2 Compositions and methods for imaging
03/01/2012WO2012027261A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes
03/01/2012WO2012026886A1 Chalcone structure fluorescence dye for embryonic stem cell probe
03/01/2012WO2012025701A1 Alpha, alpha - di substituted glycine ester derivatives and their use as hdac inhibitors
03/01/2012WO2012025450A1 Phenylamidines having a high fungicidal activity and use thereof
03/01/2012WO2012025155A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012WO2011107843A3 Process for the preparation of atazanavir sulfate substantially free of diastereomers
03/01/2012US20120053300 Functionalized polysulfide silica coupling agents and silica reinforced rubber composition for tire components
03/01/2012US20120053213 2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside hiv reverse transcriptase, preparation methods and uses thereof
03/01/2012US20120053200 Bace 2 inhibitors
03/01/2012US20120053180 Cyclohexane analogues as gpr119 agonists
03/01/2012US20120053170 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
03/01/2012CA2808590A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes
03/01/2012CA2807543A1 Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
02/2012
02/29/2012EP2423194A1 NOVEL THYROID HORMONE beta RECEPTOR AGONIST
02/29/2012EP2423193A1 Process for preparing imino compounds
02/29/2012EP2423192A1 Metal complex having aromatic ligand that contains nitrogen atom
02/29/2012EP2423189A1 Method of producing acid halide and acid halide
02/29/2012EP2423188A1 Agricultural/Horticultural Insecticide and Method for Using the Same
02/29/2012EP2422779A1 Selective ep4 receptor agonistic substance for treatment of cancer
02/29/2012EP2421832A1 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
02/29/2012EP2421831A1 Heterocyclic antiviral compounds
02/29/2012EP2421809A1 Novel organic compound, light-emitting device, and image display apparatus
02/29/2012EP2094643B1 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
02/29/2012EP1772450B1 Method for producing 1,2-dihydropyridine-2-one compound
02/29/2012CN1984881B Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives
02/29/2012CN1854119B Aminostyryl compound, method of preparing the same, and organic light emitting device using the aminostyryl compound
02/29/2012CN102365282A 9H-pyrrolo[2,3-B: 5,4-C'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
02/29/2012CN101381342B Piperazine derivatives and applications thereof
02/29/2012CN101287708B Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
02/29/2012CN101208328B Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
02/28/2012US8124807 Sulfonyl-substituted 6-membered ring derivative
02/28/2012US8124782 Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide
02/28/2012US8124777 Compound, photoelectric converter and photoelectrochemical cell
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 633